These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2503478)
1. Increased tumor control rates in murine fibrosarcoma by combined therapy with L-alanosine and radiation. Hong SS; Alfieri AA; Kim SH; Kim JH Jpn J Cancer Res; 1989 Jun; 80(6):592-6. PubMed ID: 2503478 [TBL] [Abstract][Full Text] [Related]
2. Radiosensitization of two murine fibrosarcomas with 6-thioguanine. Kim JH; Alfieri AA; Kim SH; Hong SS Int J Radiat Oncol Biol Phys; 1990 Mar; 18(3):583-6. PubMed ID: 2318691 [TBL] [Abstract][Full Text] [Related]
3. The potentiation of radiation response on murine tumor by fludarabine phosphate. Kim JH; Alfieri AA; Kim SH; Fuks Z Cancer Lett; 1986 Apr; 31(1):69-76. PubMed ID: 2421870 [TBL] [Abstract][Full Text] [Related]
4. Improved response of a murine fibrosarcoma (Meth-A) to interstitial radiation when combined with hyperthermia. Moorthy CR; Hahn EW; Kim JH; Feingold SM; Alfieri AA; Hilaris BS Int J Radiat Oncol Biol Phys; 1984 Nov; 10(11):2145-8. PubMed ID: 6490440 [TBL] [Abstract][Full Text] [Related]
5. Potentiation of radiation response in human carcinoma cells in vitro and murine fibrosarcoma in vivo by topotecan, an inhibitor of DNA topoisomerase I. Kim JH; Kim SH; Kolozsvary A; Khil MS Int J Radiat Oncol Biol Phys; 1992; 22(3):515-8. PubMed ID: 1310495 [TBL] [Abstract][Full Text] [Related]
6. Potentiation of radiation effects on two murine tumors by lonidamine. Kim JH; Alfieri AA; Kim SH; Young CW Cancer Res; 1986 Mar; 46(3):1120-3. PubMed ID: 3943089 [TBL] [Abstract][Full Text] [Related]
7. Multiple adjuvant therapy on a murine fibrosarcoma: actinomycin-D, X-irradiation and local tumor hyperthermia. Alfieri AA; Hahn EW; Kim JH; Lehman D Radiology; 1978 Oct; 129(1):225-7. PubMed ID: 693882 [TBL] [Abstract][Full Text] [Related]
8. 5-chlorodeoxycytidine, a radiosensitizer effective against RIF-1 and Lewis lung carcinoma, is also effective against a DMBA-induced mammary adenocarcinoma and the EMT-6 tumor in BALB/c mice. Greer S; Santos O; Gottlieb C; Schwade J; Marion HS Int J Radiat Oncol Biol Phys; 1992; 22(3):505-10. PubMed ID: 1735688 [TBL] [Abstract][Full Text] [Related]
9. Interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor system in vitro and in vivo. Herman TS; Teicher BA; Coleman CN Cancer Res; 1990 Aug; 50(16):5055-9. PubMed ID: 2379171 [TBL] [Abstract][Full Text] [Related]
10. The treatment of acute leukemia with continuous infusion L-Alanosine. Weick JK; Tranum BL; Morrison FS Invest New Drugs; 1983; 1(3):249-51. PubMed ID: 6678874 [TBL] [Abstract][Full Text] [Related]
11. Identification of the antimetabolite of L-alanosine, L-alanosyl-5-amino-4-imidazolecarboxylic acid ribonucleotide, in tumors and assessment of its inhibition of adenylosuccinate synthetase. Tyagi AK; Cooney DA Cancer Res; 1980 Dec; 40(12):4390-7. PubMed ID: 7438071 [TBL] [Abstract][Full Text] [Related]
12. Radiosensitization of Meth-A fibrosarcoma in mice by Lonidamine. Kim JH; Alfieri A; Kim SH; Young CW; Silvestrini B Oncology; 1984; 41 Suppl 1():36-8. PubMed ID: 6717893 [TBL] [Abstract][Full Text] [Related]
14. Determinants of the toxicity of L-alanosine to various organs of the mouse. Tyagi AK; Thake DC; McGee E; Cooney DA Toxicology; 1981; 21(1):59-69. PubMed ID: 7281196 [TBL] [Abstract][Full Text] [Related]
15. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma. Suit HD; Sedlacek R; Wagner M; Orsi L; Silobrcic V; Rothman KJ Cancer Res; 1976 Apr; 36(4):1305-14. PubMed ID: 1260756 [TBL] [Abstract][Full Text] [Related]
16. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma. Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474 [TBL] [Abstract][Full Text] [Related]
17. Expression of manganese superoxide dismutase reduces tumor control radiation dose: gene-radiotherapy. Urano M; Kuroda M; Reynolds R; Oberley TD; St Clair DK Cancer Res; 1995 Jun; 55(12):2490-3. PubMed ID: 7780953 [TBL] [Abstract][Full Text] [Related]
18. [Effect of combined use of radiation and twice intratumor administration of OK-432 at one week intervals against a murine fibrosarcoma (NFSA)]. Mukai M; Ando K; Koike S Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):631-5. PubMed ID: 3355184 [TBL] [Abstract][Full Text] [Related]
19. Contragestational profile of the tumor-inhibiting agent, L-alanosine, in the rat and the hamster. Galliani G; Assandri A; Barone D; Grandi M; Mistrello G; Lancini GC Cancer Chemother Pharmacol; 1985; 14(1):74-8. PubMed ID: 3965163 [TBL] [Abstract][Full Text] [Related]
20. [Combination therapy of local administration of OK-432 and radiation on a murine fibrosarcoma (NFSa)--combination effect and histological examination]. Mukai M; Ando K; Koike S; Ishikawa T; Ryu M; Nagashima T; Nagao K; Isono K Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):556-62. PubMed ID: 3954378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]